Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2020-09-16 Board/Management Inform…
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Biohit Oyj:n hallituksen järjestäytyminen
Board/Management Information Classification · 98% confidence The document text is very short (938 characters) and announces a specific internal corporate event: the organization of the Board of Directors ('Biohit Oyj:n hallituksen järjestäytyminen') where a Chairman was elected ('hallituksen puheenjohtajaksi Osmo Suovaniemen'). This directly relates to changes or structure within the company's governing body. This fits the definition of Board/Management Information (MANG) better than any other category, such as a general Regulatory Filing (RNS) or a Governance Report (CGR), as it is a specific, immediate announcement about the board's composition.
2020-09-16 Finnish
Biohit Oyj:n varsinaisen yhtiökokouksen päätökset
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement detailing the decisions made at Biohit Oyj's Annual General Meeting (AGM) held on September 16, 2020. It covers the approval of financial statements, dividend decisions, election of board members, appointment of auditors, and authorization for share issues. Since the document reports the specific outcomes and voting results of the AGM, it is classified as a Declaration of Voting Results & Voting Rights Announcement.
2020-09-16 Finnish
Biohit Oyj palkitsemispolitiikka.pdf
Remuneration Information Classification · 98% confidence The document is a 'Remuneration Policy' (Palkitsemispolitiikka) for Biohit Oyj. It outlines the principles and practices for compensating the Board of Directors and the CEO, including decision-making processes, performance-based incentives, and share-based compensation. This type of document is a standard governance disclosure required for shareholder approval, which falls under the 'Remuneration Information' category (DEF 14A).
2020-08-21 Finnish
Biohit Oyj:n yhtiökokouskutsu
AGM Information Classification · 100% confidence The document is an official 'yhtiökokouskutsu' (Annual General Meeting invitation) for Biohit Oyj. It details the agenda, voting procedures, and logistical information for shareholders regarding the upcoming AGM. This falls under the category of materials shared for an AGM, specifically the invitation/proxy solicitation phase.
2020-08-21 Finnish
Notice of Biohit oyj’s annual general meeting
Remuneration Information Classification · 98% confidence The document explicitly discusses the 'principles for remuneration of the Board of Directors and the President & CEO,' details the decision-making process for setting compensation, outlines main remuneration principles (fixed salary, bonus, long-term incentives), and specifies the remuneration for the Board and CEO. The text also mentions that a 'report on the remuneration will be annually presented in the company's annual general meeting.' This content directly aligns with the definition of a Remuneration Information document, which corresponds to the DEF 14A filing type (Proxy Statement/Information Statement focusing on compensation, although DEF 14A is often used broadly for compensation reports in this context, and the definition provided maps directly to compensation details). Comparing with the provided definitions: - 10-K/IR: This is not a full annual or interim financial report. - ER: This is not a brief earnings release. - DEF 14A: The definition for DEF 14A is 'Report detailing compensation for top executives and directors.' This document is entirely focused on remuneration policy and structure, making it the most appropriate classification.
2020-08-21 English
Biohit Oyj:n yhtiökokouskutsu
Remuneration Information Classification · 95% confidence The document text is written in Finnish and discusses the principles and practices for compensating the Board of Directors and the CEO of Biohit Oyj. Key phrases include 'palkitsemispolitiikka' (remuneration policy), 'hallituksen jäsenten palkitseminen' (remuneration of board members), and 'toimitusjohtaja' (CEO). It details how compensation is determined, approved by the General Meeting, and outlines principles for performance-based pay and share-based incentives. This content directly aligns with the definition of a Remuneration Information document, which corresponds to the DEF 14A filing type in the US context, or a specific governance/remuneration report in other jurisdictions. Given the provided options, 'DEF 14A' (Proxy Solicitation & Information Statement, often covering executive compensation) is the closest fit for a detailed remuneration policy document presented for shareholder approval/information, although 'CGR' (Governance Information) is also plausible. However, the focus is heavily on compensation structure, making DEF 14A the most specific match among the choices for executive/director pay details.
2020-08-21 Finnish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.